Davita INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NYSE
DVA
Davita INCDaVita Inc. reported a 6.5% increase in total consolidated revenues to $13.643 billion for fiscal year 2025, alongside a slight decrease in operating income and a significant share repurchase program.
NYSE
DVA
Davita INCDaVita Inc.'s 2024 annual report reveals a company navigating a complex regulatory environment while focusing on integrated kidney care and managing rising costs.
NYSE
DVA
Davita INCDaVita Inc.'s 2023 annual report highlights a year of navigating market challenges while focusing on strategic growth in integrated kidney care and international operations.